PLYMOUTH MEETING, Pennsylvania (WPVI) -- The FDA has given the green light to a company in Plymouth Meeting, Pennsylvania to begin testing its vaccine for COVID-19.
Inovio Pharmaceuticals calls its new vaccine INO-4800.
The vaccine is based on the DNA of the coronavirus but does not use the actual virus.
Forty adult volunteers will get two doses of the vaccine a month apart, with the first results by early summer.
Testing will be done at the University of Pennsylvania and in Kansas City.
Plymouth Meeting company gets green light to start testing COVID-19 vaccine
More TOP STORIES News